Discussion on CardioExchange: Triple Antithrombotic Therapy: What — and When — Is the Bleeding Risk?

John Ryan asks Morten Lamberts about his recent registry study of various combinations of antithrombotic agents in patients with AF and CAD (JW Cardiol Sep 26 2012). Will you continue to use triple therapy?

CardioExchange is an online community hosted by the New England Journal of Medicine and Journal Watch and dedicated to improving cardiac patient care. Membership is free for medical professionals.